CDXS
Codexis IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$255.42M
P/E Ratio
—
EPS
$-0.50
Beta
2.08
52W High
$3.87
52W Low
$0.96
50-Day MA
$1.76
200-Day MA
$2.07
Dividend Yield
—
Profit Margin
-62.50%
Forward P/E
149.25
PEG Ratio
13.53
About Codexis Inc
Codexis, Inc. discovers, develops and sells biocatalysts. The company is headquartered in Redwood City, California.
Fundamentals
| Revenue (TTM) | $70.39M |
| Gross Profit (TTM) | $8.74M |
| EBITDA | $-33.08M |
| Operating Margin | 35.90% |
| Return on Equity | -74.90% |
| Return on Assets | -16.10% |
| Revenue/Share (TTM) | $0.81 |
| Book Value | $0.56 |
| Price-to-Book | 5.07 |
| Price-to-Sales (TTM) | 3.63 |
| EV/Revenue | 3.57 |
| EV/EBITDA | -10.67 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 81.30% |
| Shares Outstanding | $90.90M |
| Float | $72.95M |
| % Insiders | 7.57% |
| % Institutions | 74.97% |
Historical Volatility
HV 10-Day
60.20%
HV 20-Day
68.75%
HV 30-Day
78.38%
HV 60-Day
100.20%
HV Rank
49.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($6.58 target)
1
Strong Buy4
Buy2
HoldData last updated: 4/30/2026